Più Attivi
Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.
Sei già registrato? Accedi
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on th... CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia. Mostra di più
Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.055 | -18.6440677966 | 0.295 | 0.3013 | 0.2399 | 1615025 | 0.26595987 | CS |
4 | -0.12 | -33.3333333333 | 0.36 | 0.37 | 0.2399 | 1919639 | 0.29042125 | CS |
12 | -0.1798 | -42.8299190091 | 0.4198 | 0.6803 | 0.2399 | 1414710 | 0.35314533 | CS |
26 | -0.83 | -77.5700934579 | 1.07 | 1.13 | 0.2399 | 1052009 | 0.46738826 | CS |
52 | -1.44 | -85.7142857143 | 1.68 | 2.39 | 0.2399 | 925645 | 0.83703813 | CS |
156 | -3.76 | -94 | 4 | 6.14 | 0.2399 | 698639 | 1.93638377 | CS |
260 | -11.5 | -97.9557069847 | 11.74 | 40.91 | 0.2399 | 788106 | 7.38243409 | CS |
Simbolo | Prezzo | Vol. |
---|---|---|
TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 3,83 (11,01%) | 103,39M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 18,79 (-8,56%) | 95,64M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,765 (3,44%) | 81,84M |
MSTUT Rex 2X Long MSTR Daily Target ETF | US$ 7,28 (-7,14%) | 65,14M |
DNNDenison Mines Corp | US$ 1,4331 (-2,51%) | 62,82M |
Nessuna Discussione Trovata |
Crea Discussione |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni